本頁面由Tiger Trade Technology Pte. Ltd.提供服務

NovaBay Pharmaceuticals Inc

1.50
-0.0300-1.96%
盤後1.40-0.1000-6.67%19:47 EDT
成交量:22.72萬
成交額:33.45萬
市值:3,993.75萬
市盈率:-0.39
高:1.60
開:1.53
低:1.42
收:1.53
52周最高:99.75
52周最低:1.11
股本:2,662.50萬
流通股本:262.44萬
量比:0.36
換手率:8.66%
股息:- -
股息率:- -
每股收益(TTM):-3.8043
每股收益(LYR):-12.6737
淨資產收益率:-516.26%
總資產收益率:-76.11%
市淨率:-1.72
市盈率(LYR):-0.12

資料載入中...

2023/05/18

SEC問詢函

Form CORRESP - Correspondence
2023/05/11

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/05/02

重要事件披露

8-K - Current report
2023/04/28

[修訂]年度報告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/04/27

重要事件披露

8-K - Current report
2023/03/31

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/31

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2023/03/31

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/02/14

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/01/20

重要事件披露

8-K - Current report
2022/12/30

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/12/13

SEC問詢函

CORRESP [Cover] - Correspondence
2022/12/09

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/11/18

重要事件披露

8-K - Current report
2022/11/14

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/11/14

重要事件披露

8-K - Current report
2022/10/27

SEC問詢函

CORRESP [Cover] - Correspondence
2022/10/25

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/10/07

重要事件披露

8-K - Current report